AKUMS DRUGS & PHARMACEUTICALS
|
|
BOM : 544222     NSE : AKUMS     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jul 18,2025 |
Price(EOD): ₹ 553.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 8,708.16 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AKUMS DRUGS & PHARMACEUTICALS | 0.3% | 2.4% | NA |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | 2.8% | 7.9% |
DIVIS LABORATORIES | -0.8% | 3.7% | 48.6% |
CIPLA | -0.2% | -0.1% | -1.9% |
TORRENT PHARMACEUTICALS | 3.4% | 11.2% | 17.9% |
DR REDDYS LABORATORIES | 0.6% | -5.2% | -4.9% |
MANKIND PHARMA | -1.7% | 14.2% | 24.9% |
ZYDUS LIFESCIENCES | 0.7% | 2.7% | -17.1% |
LUPIN | 0.3% | -0.1% | 6% |
FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AKUMS DRUGS & PHARMACEUTICALS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
25.33
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 343.78 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] 2.86
P/B Calculated based on Book Value of Rs 3,047.01 Cr
[Latest Year - Mar2025 - Consolidated Results ] 2.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,118.16 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 25753% - |
SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS
AKUMS DRUGS & PHARMACEUTICALS vs SENSEX
DEBT OF AKUMS DRUGS & PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2025 2024 2023 Avg_3yrs |
0 1.57 0.47 0.68 |
0 0.69 0.75 0.48 |
[Last Annual Data : Mar2025]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Jun2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.47% -22.62% -17.48% 125.61% |
11.79% 3041.95% 328.5% 479.06% |
QtrlyTrend |
4 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
AKUMS DRUGS & PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 1.8% | 4.6% | 16.4% |
BSE SMALLCAP | 1.5% | 4.3% | 2.1% |
BSE IPO | 0.9% | 7.1% | -3.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP 250 | 1.5% | 4.5% | 0.9% |
NIFTY IPO INDEX | 1.4% | 6.3% | NA |
NIFTY MIDSMALLCAP 400 | 1.2% | 3.1% | 1.6% |
NIFTY 500 EQUAL WEIGHT | 1.1% | 3.5% | -0.1% |
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 0.7% | 2.6% | 1.1% |
You may also like the below Video Courses
FAQ about AKUMS DRUGS & PHARMACEUTICALS
Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?
As on Jul 18,2025, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?
As on Jul 18,2025, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?
As on Jul 18,2025, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 2.14 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -8.74
Fair Value [Median EV / Sales Model] : Rs. 2.14
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 2.14
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.